BriaCell Therapeutics (BCT) Competitors C$1.00 -0.06 (-5.66%) As of 02:49 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock BCT vs. IOT, KNE, QPT, RVV, PBS, MFS, SVS, PAS, ICO, and COTShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Innovotech (IOT), Kane Biotech (KNE), Quest PharmaTech (QPT), Revive Therapeutics (RVV), Pacgen Life Science Co. (PBS.V) (PBS), Medifocus Inc. (MFS.V) (MFS), Solarvest BioEnergy (SVS), Pascal Biosciences (PAS), iCo Therapeutics (ICO), and Cotinga Pharmaceuticals Inc. (COT.V) (COT). These companies are all part of the "biotechnology" industry. BriaCell Therapeutics vs. Its Competitors Innovotech Kane Biotech Quest PharmaTech Revive Therapeutics Pacgen Life Science Co. (PBS.V) Medifocus Inc. (MFS.V) Solarvest BioEnergy Pascal Biosciences iCo Therapeutics Cotinga Pharmaceuticals Inc. (COT.V) Innovotech (CVE:IOT) and BriaCell Therapeutics (TSE:BCT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations. Is IOT or BCT more profitable? BriaCell Therapeutics has a net margin of 0.00% compared to Innovotech's net margin of -29.67%. BriaCell Therapeutics' return on equity of 536.29% beat Innovotech's return on equity.Company Net Margins Return on Equity Return on Assets Innovotech-29.67% -39.52% -33.01% BriaCell Therapeutics N/A 536.29%-122.71% Do institutionals & insiders have more ownership in IOT or BCT? 15.0% of BriaCell Therapeutics shares are owned by institutional investors. 42.9% of Innovotech shares are owned by company insiders. Comparatively, 9.3% of BriaCell Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, IOT or BCT? Innovotech has higher revenue and earnings than BriaCell Therapeutics. Innovotech is trading at a lower price-to-earnings ratio than BriaCell Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovotechC$1.23M7.61-C$390K-C$0.01-24.00BriaCell TherapeuticsN/AN/A-C$2.37M-C$1.32-0.76 Does the media refer more to IOT or BCT? In the previous week, BriaCell Therapeutics had 1 more articles in the media than Innovotech. MarketBeat recorded 1 mentions for BriaCell Therapeutics and 0 mentions for Innovotech. Innovotech's average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score. Company Overall Sentiment Innovotech Neutral BriaCell Therapeutics Neutral Which has more volatility & risk, IOT or BCT? Innovotech has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, BriaCell Therapeutics has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. SummaryBriaCell Therapeutics beats Innovotech on 6 of the 11 factors compared between the two stocks. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCT vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$2.58MC$139.24MC$5.76BC$6.26BDividend Yield13.70%3.74%3.91%6.72%P/E Ratio-0.763.8930.8265.91Price / SalesN/A4,146.09457.821,533.15Price / CashN/A13.1925.2283.29Price / Book4.8649.089.404.85Net Income-C$2.37M-C$90.99MC$3.26BC$301.20M7 Day PerformanceN/A5.49%2.07%-0.66%1 Month Performance-8.26%6.17%3.92%1.03%1 Year Performance21.95%184.12%29.08%24.75% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTBriaCell TherapeuticsN/AC$1.00-5.7%N/A+35.9%C$2.58MN/A-0.7616Gap UpIOTInnovotechN/AC$0.24-4.0%N/A+71.4%C$9.36MC$1.23M-24.001,620Gap DownKNEKane BiotechN/AC$0.05+12.5%N/A-72.4%C$6.48MC$1.42M1.13N/AGap UpHigh Trading VolumeQPTQuest PharmaTechN/AC$0.04-22.2%N/A+75.0%C$5.92MC$38.87K-1.75147,000Gap DownRVVRevive TherapeuticsN/AC$0.08+14.3%N/A+0.0%C$5.79MN/A-3.64N/ANews CoverageGap UpHigh Trading VolumePBSPacgen Life Science Co. (PBS.V)N/AC$0.03+20.0%N/A+0.0%C$1.94MC$302.08K-5.00N/AGap UpMFSMedifocus Inc. (MFS.V)N/AC$0.01flatN/A+0.0%C$1.85MC$2.23M-1.004,800SVSSolarvest BioEnergyN/AC$0.03flatN/A+0.0%C$1.52MC$740.00-0.63N/AGap DownPASPascal BiosciencesN/AC$0.02-25.0%N/A+0.0%C$984KN/A-1.506Gap DownICOiCo TherapeuticsN/AC$0.11flatN/A+0.0%C$952KN/A-10.50N/ACOTCotinga Pharmaceuticals Inc. (COT.V)N/AC$0.04-41.7%N/A+0.0%C$770KN/A-0.30N/AGap Down Related Companies and Tools Related Companies IOT Alternatives KNE Alternatives QPT Alternatives RVV Alternatives PBS Alternatives MFS Alternatives SVS Alternatives PAS Alternatives ICO Alternatives COT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:BCT) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access